The ROE as of December 2024 (TTM) for AgeX Therapeutics, Inc. (AGE) is 172.71%

According to AgeX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 172.71%. This represents a change of 268.52% compared to the average of 46.87% of the last 4 quarters.

AgeX Therapeutics, Inc. (AGE) Historical ROE (quarterly & annually)

How has AGE ROE performed in the past?

The mean historical ROE of AgeX Therapeutics, Inc. over the last ten years is -93.89%. The current 172.71% ROE has changed -283.96% with respect to the historical average. Over the past ten years (40 quarters), AGE's ROE was at its highest in in the March 2020 quarter at 431.26%. The ROE was at its lowest in in the December 2019 quarter at -122.23%.

AgeX Therapeutics, Inc. (AGE) ROE by Quarter and Year

Discovering the peaks and valleys of AgeX Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AgeX Therapeutics, Inc. (AGE) Average ROE

How has AGE ROE performed in the past?

The current ROE of AgeX Therapeutics, Inc. (AGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AgeX Therapeutics, Inc. (AGE) ROE vs. Peers

How is AGE’s ROE compared to its peers?

AgeX Therapeutics, Inc.’s ROE is less than MAIA Biotechnology, Inc. (20.47%), greater than Larimar Therapeutics, Inc. (-35.87%), greater than Graphite Bio, Inc. (-57.96%), greater than Lyra Therapeutics, Inc. (-178.68%), greater than Lineage Cell Therapeutics, Inc. (-29.91%), greater than Cadrenal Therapeutics, Inc. Common Stock (-142.95%), greater than ImmuCell Corporation (-2833.46%), greater than Oxford Nanopore Technologies plc (-32.93%), less than Praxis Precision Medicines, Inc. (0%), greater than Foghorn Therapeutics Inc. (-54.86%), less than Synaptogenix, Inc. (167.93%), greater than Invivyd, Inc. (-41.97%), greater than Biohaven Pharmaceutical Holding Company Ltd. (-155.33%), greater than Immunome, Inc. (-225.12%), greater than Inhibrx Biosciences, Inc. (-139.72%), less than Icosavax, Inc. (1.45%), greater than null (-20.22%),

Build a custom stock screener for AgeX Therapeutics, Inc. (AGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AgeX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AgeX Therapeutics, Inc. (AGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AgeX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.